CLVSF News Alert Cellavision Ab (CLVSF) 3.3344 09/26/2014 07

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cellavision Ab (CLVSF) 3.3344 $CLVSF

CellaVision AB: Interim Report January-June 2014
Thomson Reuters ONE - Fri Jul 18, 1:20AM CDT
Continued strong sales growth of 50 percent

CellaVision acquires a new technology platform
Thomson Reuters ONE - Mon Jun 23, 8:01AM CDT
This information was released for public disclosure on June 23, 2014 at 3.00 pm CET.

CellaVision revises outlook for the full year: Sales growth in 2013
Thomson Reuters ONE - Wed Jan 15, 1:26AM CST
CellaVision announces that sales for the fourth quarter of 2013 has increased significantly in comparison with the corresponding quarter in 2012. This means that the company shows sales growth for the full year 2013, in contrast to what was communicated in the company's half-year report 2013.

CellaVision AB: Interim report January - June 2013
Thomson Reuters ONE - Wed Jul 17, 1:31AM CDT
Weak quarter but continued global market initiatives and sales successes in Asia

CellaVision appoints new heads of Quality Assurance and Scientific Affairs
Thomson Reuters ONE - Mon Jun 24, 1:31AM CDT
CellaVision, which develops and sells products for routine analysis of blood and other body fluids in health care services, strengthens its organization with new positions in quality and scientific affairs. Goran Granqvist has been appointed VP Quality, responsible for Quality Assurance and part of the management team. Hans-Inge Bengtsson takes a new role as Director Scientific Affairs.

Sweden's Equalis invests in CellaVision's new product for external quality assurance of laboratory tests in hematology
Thomson Reuters ONE - Tue May 07, 4:02AM CDT
CellaVision has signed an agreement with Equalis, the Swedish provider of external quality assessment for clinical laboratory tests. Equalis has chosen to invest in CellaVision's new proficiency testing program for the identification of cells in blood and other body fluids, CellaVision® Proficiency Software. The order comprises a license for 350 users.

Bulletin from the Annual General Meeting of CellaVision AB (publ) held on April 24, 2013
Thomson Reuters ONE - Wed Apr 24, 12:39PM CDT
CellaVision AB (publ) held its Annual General Meeting today, April 24, 2013, in Lund. The meeting resolved upon the following:

CellaVision AB: Interim report January - March 2013
Thomson Reuters ONE - Wed Apr 24, 7:02AM CDT
More sales channels increase our growth opportunities but the year got off to a weak start

CellaVision and Sysmex announce a jointly-developed product for hematology labs
Thomson Reuters ONE - Tue Apr 16, 8:01AM CDT
This information was released for public disclosure on April 16, 2013 at 3.00 pm CET.

CellaVision and Beckman Coulter enhance partnership by adding EMEA to their global distribution agreement
Thomson Reuters ONE - Mon Apr 08, 1:26AM CDT
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

CellaVision's 2012 Annual Report now available
Thomson Reuters ONE - Wed Apr 03, 2:01AM CDT
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

Notice of Annual General Meeting in CellaVision AB, April 24, 2013
Thomson Reuters ONE - Thu Mar 21, 2:31AM CDT
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

NeuroVive Appoints Anna Malm Bernsten and Boel Flodgren to its Board of Directors
PR Newswire - Mon Mar 18, 5:06AM CDT
NeuroVive Pharmaceutical AB, a leading mitochondrial medicine company announces that Anna Malm Bernsten and Boel Flodgren have been elected to the Company's Board. Both have exceptional track records and leadership experience and are expected to make a significant contribution to NeuroVive.

CellaVision launches a new product for proficiency testing
Thomson Reuters ONE - Tue Mar 05, 7:01AM CST
CellaVision, which develops and sells products for routine analysis of blood and other body fluids in health care, is launching a new product for internal and external quality assurance and proficiency testing of laboratory analyses. The product, CellaVision® Proficiency Software, targets clinical laboratories that assess and perform the classification of blood cells, as well as accredited providers of external quality assessment schemes for laboratory medicine.

CellaVision adds another distribution agreement for the European market
Thomson Reuters ONE - Mon Feb 25, 5:01AM CST
This information was released for public disclosure on February 25, 2013 at 12.00 am CET.

CellaVision AB: Year-end bulletin 2012
Thomson Reuters ONE - Thu Feb 14, 1:21AM CST
Growth of 9 per cent and strengthened market position




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Davos Healthcare Aims to Revolutionize Hospital Ratings

Updated Category News Views 3

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Cracking the Code of America's Delivery Addiction

Updated Category News Views 4

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 8

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 7

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
Anecdotes by Artists Brings Raw Scent Stories to Sephora

Updated Category News Views 2

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 4

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 2

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading

Top 5 Most Recently Viewed Articles

iCoreConnect Reports Impressive Revenue Growth and New Initiatives

Updated Category News Views 121

iCoreConnect Achieves Significant Revenue Growth iCoreConnect, Inc. (NASDAQ: ICCT), a prominent provider of cloud-based software solutions, has recently reported impressive financial results for the third quarter. The company emphasizes its commitment to enhancing workflow productivity for healthcare professionals. Key Financial Highlights As of the latest quarter,...

Continue Reading
Elliot Shafer Joins Amerant Bank as New Business Leader

Updated Category News Views 217

Amerant Bank Welcomes New Leadership for Enhanced Growth Amerant Bank has recently announced a significant addition to their team with the appointment of Elliot Shafer as the Senior Vice President and Head of Business Development. This strategic hire marks a pivotal moment for the bank, which has been expanding its reach in South Florida. Shafer’s role will be central...

Continue Reading
Nutex Health Inc. Joins Russell Indexes to Boost Visibility

Updated Category News Views 107

Nutex Health Inc. Joins Prestigious Russell Indexes Nutex Health Inc. (NASDAQ: NUTX), a leader in integrated healthcare delivery, has made an exciting announcement. The company is now officially a member of both the Russell 3000 Index and the Russell Microcap Index. This addition will take effect just as the U.S. market opens on June 30, marking a significant milestone...

Continue Reading
Harnessing Influencer Power for Effective Advocacy Campaigns

Updated Category News Views 325

Transforming Advocacy Through Influencer Marketing As the public relations landscape shifts with technological advancements, River Public Affairs Group has taken a significant step forward by launching a pioneering initiative called AffinityCampaigns. Spearheaded by the adept public affairs strategist David Spady, this initiative aims to utilize influential voices from...

Continue Reading
Quarterhill Set to Reveal Q1 2025 Results with Insights

Updated Category News Views 135

Quarterhill Upcoming Q1 2025 Financial Results Quarterhill Inc. (TSX: QTRH) (OTCQX: QTRHF) is gearing up to share its financial results for the first quarter of 2025. This announcement is eagerly awaited as the company continues to solidify its position in the Intelligent Transportation System (ITS) industry. The reports, covering the three months leading up to March 31,...

Continue Reading